Clostridium difficile, also known as Clostridioides difficile and often referred to as C. difficile or C. diff, is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.
Associate Professor of Medicine
Principle Investigator: Monica Fischer, MD
Duration: 1 year
Patient Population: Adult patients receiving treatment for recurrent CDI
Study Intervention: Oral IMT or colonic IMT – questionnaire follow up for 1 year.
Enrolling: ON HOLD
Duration: 26 weeks
Patient Population: Adult patients with IBD and CDI undergoing an FMT as standard of care
Study Intervention: Bezlotuxumab Infusion in conjunction with FMT
Possibility of Placebo: 50% of not receiving Bezlotuxumab